Aquilo Capital Management, LLC Silence Therapeutics PLC Transaction History
Aquilo Capital Management, LLC
- $64.3 Million
- Q4 2024
A detailed history of Aquilo Capital Management, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Aquilo Capital Management, LLC holds 367,214 shares of SLN stock, worth $1.12 Million. This represents 3.93% of its overall portfolio holdings.
Number of Shares
367,214
Previous 317,214
15.76%
Holding current value
$1.12 Million
Previous $5.77 Million
56.22%
% of portfolio
3.93%
Previous 4.49%
Shares
8 transactions
Others Institutions Holding SLN
# of Institutions
67Shares Held
24.6MCall Options Held
500Put Options Held
5K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$9.25 Million3.41% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$8.64 Million0.86% of portfolio
-
Redmile Group, LLC San Francisco, CA2.4MShares$7.32 Million1.29% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$5.66 Million1.01% of portfolio
-
Morgan Stanley New York, NY1.66MShares$5.07 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $109M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...